Inventor
Eugeen Vanmechelen
Inventor
Nazareth-Eke, BE
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides32%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests20%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
A61KPreparations for medical, dental or toiletry purposes9%
Y10TTechnical subjects covered by former us classification7%
C12NMicroorganisms or enzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
9,447,179'Antibodies to phosphorylated tau aggregates'20168,343,493'Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs'20138,163,873'Isolated microtubule-associated protein tau peptides and kit'20128,062,842'Method for determining the risk of developing a neurological disease'20117,387,879'Diagnosis of tauopathies'20086,900,293'Monoclonal antibodies directed against the microtubule-associated protein tau'20056,680,173'Diagnosis of tauopathies'20046,670,137'Differential diagnosis of neurological diseases'20036,500,674'Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications'20026,238,892'Monoclonal antibodies directed against the microtubule-associated protein tau'20016,232,437'Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.'20016,121,003'Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use'20006,010,913'Isolated human tau peptide'20006,008,024'Monoclonal antibodies specific for PHF-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications'19995,861,257'Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications'19995,843,779'Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2013Patents assigned to INNOGENETICS NV (13)· patent assignee history
1998–2016Based in Nazareth-Eke, BE· patent location history
1999–2002Based in Nazareth, BE· patent location history
2011–2016Patents assigned to VANMECHELEN EUGEEN (4)· patent assignee history
2011Patents assigned to ABBOTT HEALTHCARE PRODUCTS BV (1)· patent assignee history
2013Patents assigned to BLANCHARD-BREGEON VERONIQUE (1)· patent assignee history
2013Patents assigned to BUEE LUC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INNOGENETICS NV | 13 | 1998–2013 |
| VANMECHELEN EUGEENself | 4 | 2011–2016 |
| ABBOTT HEALTHCARE PRODUCTS BV | 1 | 2011 |
| BLANCHARD-BREGEON VERONIQUE | 1 | 2013 |
| BUEE LUC | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Nazareth-Eke, BE | 14 | 1998–2016 |
| Nazareth, BE | 2 | 1999–2002 |